The Current Ratio as of September 2024 (TTM) for Theralink Technologies, Inc. (THER) is 0.03

According to Theralink Technologies, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.03. This represents a change of 156.59% compared to the average of 0.01 of the last 4 quarters.

Theralink Technologies, Inc. (THER) Historical Current Ratio (quarterly & annually)

How has THER Current Ratio performed in the past?

The mean historical Current Ratio of Theralink Technologies, Inc. over the last ten years is 0.68. The current 0.03 Current Ratio has changed 366.67% with respect to the historical average. Over the past ten years (40 quarters), THER's Current Ratio was at its highest in in the December 2015 quarter at 4.14. The Current Ratio was at its lowest in in the December 2017 quarter at 0.00.

Theralink Technologies, Inc. (THER) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Theralink Technologies, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theralink Technologies, Inc. (THER) Average Current Ratio

How has THER Current Ratio performed in the past?

The current Current Ratio of Theralink Technologies, Inc. (THER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Theralink Technologies, Inc. (THER) Current Ratio vs. Peers

How is THER’s Current Ratio compared to its peers?

Theralink Technologies, Inc.’s Current Ratio is less than Adhera Therapeutics, Inc. (0), greater than GB Sciences, Inc. (0.00), greater than SciSparc Ltd. (0.02), less than Creative Medical Technology Holdings, Inc. (4.10), less than Regen BioPharma, Inc. (20.21), greater than Enzolytics Inc. (0.03), less than Sonnet BioTherapeutics Holdings, Inc. (0.98), less than Inhibikase Therapeutics, Inc. (1.65), less than Sio Gene Therapies Inc. (2.32), less than Kaleido Biosciences, Inc. (21.97), greater than Tempest Therapeutics, Inc. (0), less than Lexaria Bioscience Corp. (2.17), less than Navidea Biopharmaceuticals, Inc. (0), less than ZyVersa Therapeutics, Inc. (58.27), less than Biodexa Pharmaceuticals Plc (0.56), less than Oncorus, Inc. (0.06), less than null (1.26), less than null (1.50),

Build a custom stock screener for Theralink Technologies, Inc. (THER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralink Technologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theralink Technologies, Inc. (THER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theralink Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.